Protocol Ledger

NCT04400838 · Phase II/III · COMPLETED

Investigating a Vaccine Against COVID-19

Interventional Phase II/III clinical trial protocol NCT04400838 sponsored by University of Oxford in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-05-28 Enrollment: 10,811 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04400838
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)10,811 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04400838
Protocol FieldVerified Registry Value
NCT IdentifierNCT04400838
Consolidated Lead SponsorUniversity of Oxford
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II/III
Overall Recruitment StatusCOMPLETED
Registered Enrollment10,811 participants (ACTUAL)
Registered Start Date2020-05-28
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI